ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO600

Deciphering the Role of Angpt4-Tie2 Signaling in the Kidney

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Tarjus, Antoine, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
  • Scott, Rizaldy P., Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
  • Onay, Tuncer, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
  • Quaggin, Susan E., Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States

Group or Team Name

  • Quaggin lab
Background

The angiopoietin-Tie2 signaling pathway is fundamental for vascular development and has been linked to numerous kidney diseases including diabetic nephropathy and sepsis-related AKI. The pathway is composed of two receptors, Tie1 and Tie2, and three ligands, Angiopoiein-1, Angiopoietin-2 and Angiopoietin-4 (Angpt-4). Among the ligands, Angpt-4 has been poorly characterized. While Angpt4 has been suggested to act as a Tie2 agonist and seems to be highly regulated by hypoxia, its physiological role remains elusive. Moreover, the study of Angpt-4 function is currently challenging due to the lack of knockout transgenic model. In order to decipher its physiological role, we have developed a new Angpt4 mouse model.

Methods

We generated a new reporter and conditional allele for Angpt4 in mice. Using the X-gal chromogenic substrate of the β-galactosidase, this model allows us to characterize high-resolution expression pattern of Angpt-4. To identify the cell type expressing Angpt-4, we performed immunohistochemical staining on tissue sections using antibody coupled with the alkaline phosphatase enzyme. Global and timed deletion of Angpt4 was accomplished using ubiquitous and tetON inducible Cre-deletor lines.

Results

X-gal staining reveals strong expression restricted to the vasculature of organs including the kidney, adrenal glands, gonads, and mesentery. In the kidney, X-gal staining is found in the renal and interlobular arteries. Using an antibody against Transgelin (SM22), a marker of smooth muscle cells, we show Angpt-4 co-localizes with vascular smooth muscle cells in the kidney. Global KO mice survive to birth and renal function testing is underway.

Conclusion

Our data demonstrate a highly specific vascular pattern of expression for Angpt-4 in smooth muscle cells of the vascular wall. These observations suggest that Angpt-4 may have a role in arterial function with potential impact in the pathology of renal ischemia as Angpt-4 has been shown to be regulated by hypoxia.